The largest database of trusted experimental protocols

3 protocols using dithiothreitol (dtt)

1

Yeast Autophagy Protein Localization

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents were from Sigma, except where indicated, with the following stock compositions. Yeast nitrogen base (Difco); Choline (1 M stock in DDW); Rapamycin (GoldBio; primary stock solution: 2.5 mg/ml in 100% ethanol, and secondary stock of 1 mg/ml in 90% ethanol+10% Tween‐20 (v:v), final 200 ng/ml). Copper sulfate (used at 500 μM from a 0.5 M stock in DDW). Potassium Permanganate (Dissolved in DDW), S‐1 (or Dimethylethanolamine)—Ted‐Pella−18315. BEEM embedding capsules size 00, EMS, 70010‐B. Proteinase K (stock 2 mg/ml, final 100 mg/ml (diluted in PS200)); Triton X‐100 (stock 40% (w/v), final 0.4% (w/v)); DTT (Bio Basic Inc); PMSF (200 mM in EtOH); Z1000 Zymolyase 20T (US biological); Sodium‐Sulfate (BDH); Mouse anti‐GFP (MBL); mouse anti‐Pgk1 (Abcam); Rabbit anti‐Ape1 (polyclonal antibodies prepared by using two synthetic peptides that were conjugated to keyhole limpet hemocyanin (KLH) and then injected into rabbits to produce an anti‐Ape1 antiserum that recognizes both precursor and mature forms); Anti‐cpy1 polyclonal antibody (obtained from Prof. Howard Riezman); pRS316‐GFP‐Atg8 (expressed under the promoter of Atg8, kind gift from Prof. Yoshinori Ohsumi); pDP105 (expressing TagBFP‐Ape1 under the native Ape1 promoter and Ape1 under the pCUP1 promoter, kind gift from Prof. Claudine Kraft).
+ Open protocol
+ Expand
2

Strains and Reagents for C. albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains, plasmids and oligonucleotides used in this study are listed in Tables S1–S4. All C. albicans strains were maintained on YEPD medium (1% yeast extract, 2% bacto peptone, 2% glucose and 2% agar for solidification). Prototropic transformants were selected on a synthetic medium (2% dextrose, 1.7% Difco yeast nitrogen base with ammonium sulfate and auxotrophic supplements). For nourseothricin‐resistant mutants, 200 μg ml−1 of nourseothricin (Werner Bioagents, Jena, Germany) was added to the YEPD. To obtain nourseothricin‐sensitive transformants, strains were grown in YPM (1% yeast extract, 2% peptone and 2% maltose) for 8 hr and plated on YPM plates containing 25 μg ml−1 nourseothricin for 48 hr. Except for sodium dodecyl sulfate (SDS; Biobasic, Inc.) and DTT (SRL), all the supplements and chemicals; β‐mercaptoethanol, tunicamycin, fluconazole, ketoconazole, voriconazole, amphotericin B, calcofluor white and congo red were purchased from Sigma‐Aldrich. Caspofungin was obtained from Merck & Co. Inc., NJ.
+ Open protocol
+ Expand
3

C. albicans Strain Preparation and Handling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains, plasmids and oligonucleotides used in this study are listed in Table S1S4. All C. albicans strains were maintained on YEPD medium (1% yeast extract, 2% bacto peptone, 2% glucose and 2% agar for solidification). Prototropic transformants were selected on a synthetic medium (2% dextrose, 1.7% Difco yeast nitrogen base with ammonium sulfate and auxotrophic supplements). For nourseothricinresistant mutants, 200 μg ml−1 of nourseothricin (Werner Bioagents, Jena, Germany) was added to the YEPD. To obtain nourseothricin-sensitive transformants, strains were grown in YPM (1% yeast extract, 2% peptone and 2% maltose) for 8 hr and plated on YPM plates containing 25 μg ml−1 nourseothricin for 48 hr. Except for sodium dodecyl sulfate (SDS; Biobasic, Inc.) and DTT (SRL), all the supplements and chemicals; β-mercaptoethanol, tunicamycin, fluconazole, ketoconazole, voriconazole, amphotericin B, calcofluor white and congo red were purchased from Sigma-Aldrich. Caspofungin was obtained from Merck & Co. Inc., NJ.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!